Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

APYX stock hub

Apyx Medical Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

APYXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

153.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

APYX

In the news

Latest news · APYX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-76.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-5.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All APYX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000719135
Company name	Apyx Medical Corporation
Country	United States
Country code	US
Cusip	03837C106
Employees	205
Employees Change	-15%
Employees Change Percent	-6.82
Enterprise value	$161.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	1987-01-01
Isin	US03837C1062
Last refreshed	2026-05-10
Market cap	$153.5M
Market cap category	Micro-Cap
Price	$3.67
Price currency	USD
Rev Per Employee	272,702.44x
Sector	Healthcare
Sic	3841
Symbol	APYX
Website	https://apyxmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.97%
EV Sales Forward	2.74x
EV/Sales	2.89x
FCF yield	-5.86%
P/B ratio	11.97x
P/S ratio	2.75x
PS Forward	2.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.7%
EBITDA Margin	-6.42%
Gross margin	63.15%
Gross Profit	$35.3M
Gross Profit Growth	21.42%
Gross Profit Growth Q	39.89%
Gross Profit Growth3 Y	7.42%
Gross Profit Growth5 Y	11.62%
Net Income	$-9.2M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-15.58%
Profit Margin	-16.4%
Profit Per Employee	$-44,727
ROA	-4.37
Roa5y	-15.67
ROCE	-8.04
ROE	-76.49
Roe5y	-65.02
ROIC	-5.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.09%
Cagr15y	1.31%
Cagr1y	193.82%
Cagr20y	-0.42%
Cagr3y	2.18%
Cagr5y	-17.5%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	18.22x
Revenue Growth Q	32.45x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	8.18x
Revenue Growth5 Y	12.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.91
Assets	$63M
Cash	$31.1M
Current Assets	$54.8M
Current Liabilities	$9.4M
Debt	$39.5M
Debt Equity	$3.02
Equity	$13.1M
Interest Coverage	-0.77
Liabilities	$49.9M
Long Term Assets	$8.2M
Long Term Liabilities	$40.5M
Net Cash	$-8.3M
Net Cash By Market Cap	$-5.42
Net Debt Equity	$0.64
Tangible Book Value	$12.8M
Tangible Book Value Per Share	$0.31
WACC	11.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.8
Inventory Turnover	2.39
Net Working Capital	$14.7M
Quick ratio	4.65
Working Capital	$45.3M
Working Capital Turnover	$1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	98.39%
1Y total return	193.6%
200-day SMA	3.25
3Y total return	6.69%
50-day SMA	3.61
50-day SMA vs 200-day SMA	50over200
5Y total return	-61.77%
All Time High	17.5
All Time High Change	-79.03%
All Time High Date	2021-11-22
All Time Low	0.34
All Time Low Change	967.48%
All Time Low Date	1999-07-13
ATR	0.3
Beta	1.35
Beta1y	1.31
Beta2y	2
Ch YTD	4.86
High	3.82
High52	4.5
High52 Date	2026-02-02
High52ch	-18.44%
Low	3.4
Low52	1.08
Low52 Date	2025-05-12
Low52ch	239.82%
Ma50ch	1.66%
Premarket Change Percent	-4.49
Premarket Price	$3.4
Premarket Volume	1,857
Price vs 200-day SMA	13.03%
RSI	53.67
RSI Monthly	56.07
RSI Weekly	53.34
Sharpe ratio	1.52x
Sortino ratio	2.97
Total Return	-10.75%
Tr YTD	4.86
Tr15y	21.52%
Tr1m	-2.13%
Tr1w	19.94%
Tr3m	-5.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.11
Earnings Revenue Estimate	10,969,440x
Earnings Revenue Estimate Growth	16.32x
Operating Income	$-4.3M
Operating margin	-7.7
Price target	$6.5
Price Target Change	$77.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,090,399%
Float Percent	69.55%
Net Borrowing	-20,000
Shares Insiders	13.27%
Shares Institutions	28.67%
Shares Out	41,829,226
Shares Qo Q	-0.01%
Shares Yo Y	10.75%
Short Float	0.67%
Short Ratio	1.52
Short Shares	0.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.9M
Average Volume	214,908.75x
Bv Per Share	0.31
CAPEX	$-1.1M
Ch10y	98.38
Ch15y	21.52
Ch1m	-2.13
Ch1w	19.94
Ch1y	193.6
Ch20y	-8.02
Ch3m	-5.41
Ch3y	6.69
Ch5y	-61.77
Ch6m	-5.17
Change	3.09%
Change From Open	7.88
Close	3.56
Days Gap	-4.44
Depreciation Amortization	719,000
Dollar Volume	942,389.9
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-4.3M
EBITDA	$-3.6M
EPS	$-0.22
F Score	4
FCF	$-9M
FCF EV Yield	-5.55x
FCF Per Share	$-0.21
Financing CF	9,638,000
Fiscal Year End	December
Founded	1,982
Income Tax	$364,000
Investing CF	-1,119,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	1994-01-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	3.64
Ma150ch	0.96%
Ma20	3.59
Ma20ch	2.23%
Net CF	126,000
Next Earnings Date	2026-08-06
Open	3.4
Optionable	Yes
Position In Range	64.29
Post Close	3.67
Postmarket Change Percent	-0.54
Postmarket Price	$3.65
Ppne	6,349,000
Pre Close	3.56
Price Date	2026-05-08
Ptbv Ratio	11.96
Relative Volume	1.19x
Revenue	55,904,000x
SBC By Revenue	3.33x
Share Based Comp	1,862,000
Tax By Revenue	0.65x
Tr20y	-8.02%
Tr6m	-5.17%
Us State	Florida
Volume	256,782

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does APYX pay a dividend?

Capital-return profile for this ticker.

Performance

APYX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns APYX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.7%

Float: +69.5% of shares outstanding

Insider ownership

+13.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

APYX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.7

Neutral momentum band

Price vs 200-day MA

+13.0%

50/200-day relationship not available

Beta (5Y)

1.35

More volatile than the market

Sharpe ratio

1.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About APYX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current APYX stock rating?

Apyx Medical Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full APYX analysis?

The full report lives at /stocks/APYX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for APYX?

The latest report frames APYX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the APYX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.